Will Chou, MD.

Company: Aruvant

Job title: CEO

Seminars:

Developing a Differentiated Gene Therapy for Sickle Cell Disease: Key Considerations 9:00 am

Aligning with regulatory requirements for quality of gene therapies, across CMC & clinical development Standing out from both a safety and efficacy perspective Developing therapies in a ‘crowded’ market – with respect to gene therapies in development and existing standards of careRead more

day: Day Two